NB
Nascent Biotech, Inc.
NBIO · OTC
$0.00 +0.00% (+$0.00)
1M -33.33%
Market Cap $34.4K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/S 11,481.10x
EV/FFO N/A
P/B N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 44,926,500.00%
Op. margin 50,236,100.00%
FCF margin 44,936,300.00%
Quality
57 /100
Average ROA 741.27%
Asset turnover 0.00x
ROIC 213.86%
Debt
0 /100
High Int. coverage -59.09x
Current ratio 0.19x
Net debt/EBITDA N/A
Stability
5 /100
Unstable EPS volatility 283.98%
Profitable years 0
Beta 1.76x
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre NBIO
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Sean Carrick
Employees
2
Headquarters
North Palm Beach